NCT02201420View on ClinicalTrials.gov

Evaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposi's Sarcoma and Lymphatic Drainage by SPECT/CT

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

October 31, 2015

Conditions
Kaposi's Sarcoma
Interventions
DRUG

Tc 99m tilmanocept

Trial Locations (1)

94143

San Francisco General Hospital, San Francisco

Sponsors
All Listed Sponsors
lead

Navidea Biopharmaceuticals

INDUSTRY